课题基金 / 基金详情

RIBOSOMAL FUNCTION & ANTIBIOTIC DESIGN

RIBOSOMAL FUNCTION & ANTIBIOTIC DESIGN
核糖体功能
批准号:
6815961
负责人:
Shahriar Mobashery
金额:
$15.33万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-08-01 至 2007-12-31

项目摘要

项目成果

Shahriar Mobashery的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):最近几种核糖体的X射线晶体结构的可用性在该领域引起了相当大的兴奋。这些结构将有助于设计实验,以阐明蛋白质的核糖体合成的细节。此外,细菌核糖体是许多类抗生素的靶标,每一类抗生素都干扰蛋白质合成的生物化学方面。对核糖体结构的研究将在不久的将来引领开发新型抗生素的道路。这个多学科合作项目的长期目标是利用已知X射线结构的结构信息,更详细地研究核糖体功能,并开发一种重要和通用的生物合成过程的新型抑制剂。提出了四个具体目标。1)分子动力学模拟和实验的结合将用于探索在肽键形成过程中的解码过程的动态性质,并了解抗生素结合在这个过程中的作用。2)将合成两种分子,用于研究rRNA A位点在解码过程中的运动,并研究rRNA结合。这些化合物是A位点功能的潜在抑制剂,因此可能是抗菌剂。3)将合成氨基糖苷类-EDTA复合物的两种铁复合物,并检测其结合核糖体和在核糖体结合位点内片段化rRNA骨架的能力。这些实验将确定这些抗生素结合的位置,并通过检查切割模式提供有关动力学的信息。4)具体目标4扩展了早期在设计新抗生素方面的成功。将产生一系列通过结合到核糖体A位点来干扰蛋白质合成的分子。一系列具体分析(用活细菌评估抗菌特性,翻译测定,细菌膜渗透性测定,细菌中DNA和RNA功能测定,细胞毒性测定,用A位点突变的30 S核糖体和携带它们的细菌的测定,30 S核糖体和与新抗生素复合的A位点模型的X射线分析)已经设想用于研究这些分子的抗菌性质。这一集体努力将阐明核糖体内的各种分子事件以及如何抑制其中一些过程。
英文摘要
DESCRIPTION (provided by applicant): The recent availability of several x-ray crystal structures for the ribosome have created considerable excitement in the field. These structures will be instrumental in devising experiments to elucidate the details of ribosomal synthesis of proteins. Furthermore, the bacterial ribosome is the target of many classes of antibiotics, each of which interferes with an aspect of the biochemistry of protein synthesis. Studies of ribosome structures will lead the way in developing novel classes of antibiotics in the near future. The long-term goal of this multidisciplinary collaborative project is to utilize the structural information from known x-ray structures to study ribosome function in greater detail and to develop novel inhibitors of an essential and universal biosynthetic process. Four specific aims are proposed. 1) A combination of molecular dynamics simulations and experiments will be used to explore the dynamic nature of the decoding process during peptide-bond formation and to understand the role of antibiotic binding in this process. 2) Two molecules that have been designed to explore the motion of the rRNA A site during the decoding process will be synthesized and studied for rRNA binding. These compounds are potential inhibitors of A site function, hence possible antibacterials. 3) Two iron complexes of aminoglycoside-EDTA complexes will be synthesized and tested for their ability to bind the ribosome and fragment the rRNA backbone at sites located within the antibiotic-binding site(s). These experiments will identify the locations in which these antibiotics bind, as well as provide information about dynamics through examination of cleavage patterns. 4) Specific aim 4 expands on earlier success in the design of new antibiotics. A series of molecules that will interfere with protein synthesis by binding to the ribosomal A site will be generated. A host of specific analyses (assessment of antibacterial properties with living bacteria, translation assays, bacterial membrane permeability assay, assays for DNA and RNA function in bacteria, cytotoxicity assays, assays with A-site mutated 30S ribosomes and bacteria that harbor them, and x-ray analyses of the 30S ribosome and the A-site model complexed with the novel antibiotics) have been envisioned for the study of the antibacterial properties of these molecules. This collective effort will shed light both on the various molecular events within the ribosomal and on how to inhibit some of these processes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Bulgecin Template for Potentiation of beta-Lactam Antibiotics
  • 批准号:
    10040793
  • 项目类别:
  • 资助金额:
    $50.2万
  • 财政年份:
    2020
  • 负责人:
    Shahriar Mobashery
  • 依托单位:
Bulgecin Template for Potentiation of beta-Lactam Antibiotics
  • 批准号:
    10203804
  • 项目类别:
  • 资助金额:
    $62.9万
  • 财政年份:
    2020
  • 负责人:
    Shahriar Mobashery
  • 依托单位:
Bulgecin Template for Potentiation of beta-Lactam Antibiotics
  • 批准号:
    10631928
  • 项目类别:
  • 资助金额:
    $62.9万
  • 财政年份:
    2020
  • 负责人:
    Shahriar Mobashery
  • 依托单位:
Bulgecin Template for Potentiation of beta-Lactam Antibiotics
  • 批准号:
    10438764
  • 项目类别:
  • 资助金额:
    $62.9万
  • 财政年份:
    2020
  • 负责人:
    Shahriar Mobashery
  • 依托单位:
海外基金